• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳布啡对全腹子宫切除术后恶心呕吐的影响。

Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.

作者信息

Lewis I H, Campbell D N, Barrowcliffe M P

机构信息

Department of Anaesthetics, Royal Hampshire County Hospital, Winchester.

出版信息

Br J Anaesth. 1994 Aug;73(2):244-6. doi: 10.1093/bja/73.2.244.

DOI:10.1093/bja/73.2.244
PMID:7917745
Abstract

In a prospective, double-blind study, we have examined the effect of preoperative nabilone on postoperative nausea and vomiting (PONV). Sixty women, less than 70 yr old, undergoing total abdominal hysterectomy, were allocated randomly to receive either nabilone 2 mg or metoclopramide 10 mg orally 90 min before induction of anaesthesia. The study was designed to detect a 50% difference in the incidence of postoperative vomiting between the two groups, with an 80% power of achieving a statistically significant result at the 5% level. Data from 53 patients were analysed: the incidences of nausea and vomiting for the metoclopramide group were 70% and 67%, respectively; the corresponding values for the nabilone group were 73% and 54%. These differences were not significant.

摘要

在一项前瞻性双盲研究中,我们研究了术前使用纳布啡对术后恶心和呕吐(PONV)的影响。60名年龄小于70岁、接受全腹子宫切除术的女性被随机分配,在麻醉诱导前90分钟口服2毫克纳布啡或10毫克甲氧氯普胺。该研究旨在检测两组术后呕吐发生率50%的差异,在5%的水平上有80%的把握获得具有统计学意义的结果。对53例患者的数据进行了分析:甲氧氯普胺组恶心和呕吐的发生率分别为70%和67%;纳布啡组的相应值分别为73%和54%。这些差异无统计学意义。

相似文献

1
Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.纳布啡对全腹子宫切除术后恶心呕吐的影响。
Br J Anaesth. 1994 Aug;73(2):244-6. doi: 10.1093/bja/73.2.244.
2
Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery.多潘立酮、氟哌利多与甲氧氯普胺用于预防妇科大手术后恶心呕吐的比较。
Br J Anaesth. 1986 Aug;58(8):884-7. doi: 10.1093/bja/58.8.884.
3
Comparison of ondansetron and metoclopramide for the prevention of post-operative nausea and vomiting after major gynaecological surgery.
Eur J Anaesthesiol. 1996 Sep;13(5):485-91. doi: 10.1046/j.1365-2346.1996.d01-392.x.
4
Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron.月经期间女性患者术后恶心呕吐的预防:氟哌利多、甲氧氯普胺和格拉司琼的比较
Br J Anaesth. 1998 Feb;80(2):248-9. doi: 10.1093/bja/80.2.248.
5
Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.昂丹司琼与胃复安预防妇科手术后恶心呕吐的比较
J Med Assoc Thai. 2008 May;91(5):669-74.
6
[Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].[甲状腺手术后恶心呕吐的预防:口服和静脉注射多潘立酮与静脉注射氟哌利多及安慰剂的比较]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Jul;36(7):425-30. doi: 10.1055/s-2001-15436.
7
Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study.纳布啡和胃复安治疗顺铂所致恶心和呕吐的双盲研究。
Med Oncol Tumor Pharmacother. 1986;3(1):39-42. doi: 10.1007/BF02934575.
8
Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide.术后恶心呕吐的治疗:丙泊酚、氟哌利多和甲氧氯普胺的比较。
Can J Anaesth. 1996 Feb;43(2):115-20. doi: 10.1007/BF03011251.
9
Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy.格拉司琼、氟哌利多和胃复安预防甲状腺切除术后恶心和呕吐的效果观察
Laryngoscope. 1999 Apr;109(4):664-7. doi: 10.1097/00005537-199904000-00028.
10
[Evaluation of the administration time of ondansetron, a preventive for postoperative nausea and vomiting: prospective, randomized, double-blind study in 120 patients].[昂丹司琼预防术后恶心呕吐给药时间的评估:120例患者的前瞻性、随机、双盲研究]
Anaesthesist. 1997 Jul;46(7):583-7. doi: 10.1007/s001010050440.

引用本文的文献

1
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.医用大麻素:基于药理学的系统评价和荟萃分析,涵盖所有相关医学适应证。
BMC Med. 2022 Aug 19;20(1):259. doi: 10.1186/s12916-022-02459-1.
2
A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework.一项综合患者及公众参与计划,采用定性主题框架评估大麻衍生药用产品在治疗急性术后疼痛、恶心和呕吐方面的认知情况。
Cannabis Cannabinoid Res. 2020 Feb 27;5(1):73-80. doi: 10.1089/can.2019.0020. eCollection 2020 Mar 1.
3
Cannabis-based medicines and the perioperative physician.
基于大麻的药物与围手术期医生。
Perioper Med (Lond). 2019 Dec 6;8:19. doi: 10.1186/s13741-019-0127-x. eCollection 2019.
4
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.合成与非合成大麻素类药物及其不良反应——基于公共卫生视角的综述
Front Public Health. 2018 Jun 7;6:162. doi: 10.3389/fpubh.2018.00162. eCollection 2018.
5
Management of postoperative nausea and vomiting: focus on palonosetron.术后恶心呕吐的管理:以帕洛诺司琼为重点。
Ther Clin Risk Manag. 2009 Feb;5(1):21-34. Epub 2009 Mar 26.
6
Drugs for preventing postoperative nausea and vomiting.预防术后恶心呕吐的药物。
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD004125. doi: 10.1002/14651858.CD004125.pub2.
7
[Review of cannabinoids in the treatment of nausea and vomiting].[大麻素类药物治疗恶心和呕吐的综述]
Schmerz. 2004 Aug;18(4):306-10. doi: 10.1007/s00482-004-0315-5.
8
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.大麻素用于控制化疗引起的恶心和呕吐:定量系统评价
BMJ. 2001 Jul 7;323(7303):16-21. doi: 10.1136/bmj.323.7303.16.